Publisher
Springer International Publishing
Reference23 articles.
1. Allbritton JI, Nousari HC, Anhalt GJ (1997) Anti-epiligrin (laminin 5) cicatricial pemphigoid. Br J Dermatol 137:992–996
2. Amagai M, Tsunoda K, Suzuki H, Nishifuji K, Koyasu S, Nishikawa T (2000) Use of autoantigen-knockout mice in developing an active autoimmune disease model for pemphigus. J Clin Invest 105:625–631
3. Anhalt GJ, Patel HP, Labib RS, Diaz LA, Proud D (1986a) Dexamethasone inhibits plasminogen activator activity in experimental pemphigus in vivo but does not block acantholysis. J Immunol 136:113–117
4. Anhalt GJ, Till GO, Diaz LA, Labib RS, Patel HP, Eaglstein NF (1986b) Defining the role of complement in experimental pemphigus vulgaris in mice. J Immunol 137:2835–2840
5. Buschard K, Dabelsteen E, Bretlau P (1981) A model for the study of autoimmune diseases applied to pemphigus: transplants of human oral mucosa to athymic nude mice binds pemphigus antibodies in vivo. J Invest Dermatol 76:171–173